| NAME |
FLUTICASONE 200/UMECLIDINIUM 62.5/VILANTEROL 25MCG/ACTUAT INH,30 |
| VA GENERIC NAME |
FLUTICASONE/UMECLIDINIUM/VILANTEROL |
| DOSAGE FORM |
INHL,ORAL |
| FDA MED GUIDE |
Fluticasone-Umeclidinium-Vilanterol_(Trelegy_Ellipta)_(2017).pdf |
| HAZARDOUS TO DISPOSE |
NO |
| ACTIVE INGREDIENTS |
|
| CS FEDERAL SCHEDULE |
Unscheduled |
| SINGLE/MULTI SOURCE PRODUCT |
Multisource |
| NATIONAL FORMULARY NAME |
FLUTICASONE/UMECLIDINIUM/VILANTEROL INHL,ORAL |
| CREATE DEFAULT POSSIBLE DOSAGE |
YES |
| CODING SYSTEM |
|
| COPAY TIER |
-
- COPAY TIER LEVEL: 3
- COPAY EFFECTIVE DATE: 2020-10-16 00:00:00
|
| PGX ELIGIBLE |
NO |
| PGX SUPPRESSED |
NO |
| VA PRINT NAME |
TRELEGY ELLIPTA 200/62.5/25MCG INH 30D |
| VA PRODUCT IDENTIFIER |
T1074 |
| TRANSMIT TO CMOP |
YES |
| VA DISPENSE UNIT |
INHALER |
| MASTER ENTRY FOR VUID |
YES |
| VUID |
4039752 |
| EFFECTIVE DATE/TIME |
-
- 2020-10-16 00:00:00
- STATUS: ACTIVE
-
- 2020-10-16 00:00:00
- STATUS: ACTIVE
-
- 2020-10-16 00:00:00
- STATUS: ACTIVE
|